Globus Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. It engages in developing products that promote healing in patients with musculoskeletal disorders. 

CEO
Keith W. Pfeil
CEOKeith W. Pfeil
Employees
6,000
Employees6,000
Headquarters
Audubon, Pennsylvania
HeadquartersAudubon, Pennsylvania
Founded
2003
Founded2003
Employees
6,000
Employees6,000

GMED Key Statistics

Market cap
12.85B
Market cap12.85B
Price-Earnings ratio
24.32
Price-Earnings ratio24.32
Dividend yield
Dividend yield
Average volume
1.36M
Average volume1.36M
High today
$96.00
High today$96.00
Low today
$92.79
Low today$92.79
Open price
$94.73
Open price$94.73
Volume
1.18M
Volume1.18M
52 Week high
$101.40
52 Week high$101.40
52 Week low
$51.79
52 Week low$51.79

Stock Snapshot

As of today, Globus Medical(GMED) shares are valued at $95.46. The company's market cap stands at 12.85B, with a P/E ratio of 24.32.

On 2026-03-02, Globus Medical(GMED) stock moved within a range of $92.79 to $96.00. With shares now at $95.46, the stock is trading +2.9% above its intraday low and -0.6% below the session's peak.

Trading activity shows a volume of 1.18M, compared to an average daily volume of 1.36M.

The stock's 52-week range extends from a low of $51.79 to a high of $101.40.

The stock's 52-week range extends from a low of $51.79 to a high of $101.40.

GMED News

Simply Wall St 2d
Globus Medical Is Up 5.4% After Record 2025 Earnings and Raised EPS Outlook Has The Bull Case Changed?

In late February 2026, Globus Medical reported record Q4 2025 and full-year 2025 results, with sales rising to US$826.42 million for the quarter and US$2.94 bil...

Globus Medical Is Up 5.4% After Record 2025 Earnings and Raised EPS Outlook Has The Bull Case Changed?
Investor's Business Daily 2d
GE Aerospace, Nuclear Play Lead 5 Stocks Near Buy Points

News GE Aerospace, Nuclear Play Lead 5 Stocks Near Buy Points Licensing GE Aerospace (GE) and nuclear components supplier BWX Technologies (BWXT) lead this week...

GE Aerospace, Nuclear Play Lead 5 Stocks Near Buy Points
TipRanks 4d
Globus Medical Earnings Call Shows Profitable Growth

Globus Medical ((GMED)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level data...

Analyst ratings

65%

of 17 ratings
Buy
64.7%
Hold
29.4%
Sell
5.9%

More GMED News

Simply Wall St 4d
Is It Too Late To Consider Globus Medical After Recent Share Price Strength?

If you are wondering whether Globus Medical's current share price reflects its true worth, you are not alone. This article focuses squarely on what the numbers...

Is It Too Late To Consider Globus Medical After Recent Share Price Strength?
TipRanks 5d
Globus Medical: Strengthening U.S. Spine Momentum and Innovation-Driven Double-Digit Growth Supports Buy Rating and Upside Valuation

TD Cowen analyst Mathew Blackman maintained a Buy rating on Globus Medical today and set a price target of $112.00. Mathew Blackman has given his Buy rating du...

TipRanks 5d
Globus Medical price target raised to $123 from $118 at Barclays

Barclays analyst Matt Miksic raised the firm’s price target on Globus Medical (GMED) to $123 from $118 and keeps an Overweight rating on the shares following th...

Nasdaq 5d
Globus Medical, Inc. Reports Advance In Q4 Profit

(RTTNews) - Globus Medical, Inc. (GMED) revealed earnings for its fourth quarter that Increases, from last year The company's bottom line came in at $140.59 mi...

Globus Medical, Inc. Reports Advance In Q4 Profit
TipRanks 5d
Globus Medical reports Q4 EPS $1.28, consensus 96c

Reports Q4 revenue $826.4M, consensus $803.29M. “Momentum built throughout 2025 accelerated in the fourth quarter, capping off a strong finish to the year with...

People also own

Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.